Atlas Trials

Locally Advanced Bladder Urothelial Carcinoma

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Advanced Bladder Urothelial Carcinoma

RecordFirmDate
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153)National Cancer Institute (NCI)2022-07-07
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy (NCT04637594)Alliance for Clinical Trials in Oncology2022-05-27
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299)M.D. Anderson Cancer Center2021-09-23
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma (NCT04848519)Emory University2021-05-20
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780)National Cancer Institute (NCI)2018-07-20
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer (NCT03244384)National Cancer Institute (NCI)2017-11-03
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations (NCT03047213)National Cancer Institute (NCI)2017-08-24

Track Locally Advanced Bladder Urothelial Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.